Effective exosomes reduction in hypercholesterinemic patients suffering from cardiovascular diseases by lipoprotein apheresis: Exosomes apheresis

被引:0
作者
Schroeder, Sophie [1 ]
Epple, Robert [1 ]
Fischer, Andre [1 ,2 ,3 ]
Schettler, Volker J. J. [4 ,5 ]
机构
[1] German Ctr Neurodegenerat Dis DZNE Gottingen, Dept Epigenet & Syst Med Neurodegenerat Dis, Gottingen, Germany
[2] Univ Med Ctr Gottingen, Dept Psychiat & Psychotherapy, Gottingen, Germany
[3] Univ Gottingen, Cluster Excellence Multiscale Bioimaging Mol Machi, Gottingen, Germany
[4] Ctr Nephrol Gottingen GbR, Gottingen, Germany
[5] Nephrol Zentrum Gottingen GbR, An der Lutter 24, D-37075 Gottingen, Germany
关键词
coronary heart disease; exosomes; hemodialysis; lipoprotein apheresis; risk reduction; EXTRACELLULAR VESICLES; ATHEROSCLEROSIS; MICROPARTICLES; RISK;
D O I
10.1111/1744-9987.14172
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionExtracellular vesicles (EVs) have been identified as playing a role in atherosclerosis.MethodsA group of 37 hypercholesterolemic patients with atherosclerotic cardiovascular diseases (ASCVD) and 9 patients requiring hemodialysis (HD) were selected for the study.ResultsEVs were comparably reduced by various LA methods (Thermo: 87.66% +/- 3.64, DALI: 87.96% +/- 4.81, H.E.L.P.: 83.38% +/- 11.98; represented as SEM). However, LDL-C (66%; 55%; 75%) and Lp(a) (72%; 67%; 79%) were less effectively reduced by DALI. There was no significant difference in the reduction of EVs when comparing different techniques, such as hemoperfusion (DALI; n = 13), a precipitation (H.E.L.P.; n = 5), and a double filtration procedure (Thermofiltration; n = 19). Additionally, no effect of hemodialysis on EVs reduction was found.ConclusionsThe study suggests that EVs can be effectively removed by various LA procedures, and this effect appears to be independent of the specific LA procedure used, as compared to hemodialysis.
引用
收藏
页码:863 / 870
页数:8
相关论文
共 34 条
  • [21] 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes Developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC)
    Marx, Nikolaus
    Federici, Massimo
    Schuett, Katharina
    Mueller-Wieland, Dirk
    Ajjan, Ramzi A.
    Antunes, Manuel J.
    Christodorescu, Ruxandra M.
    Crawford, Carolyn
    Di Angelantonio, Emanuele
    Eliasson, Bjorn
    Espinola-Klein, Christine
    Fauchier, Laurent
    Halle, Martin
    Herrington, William G.
    Kautzky-Willer, Alexandra
    Lambrinou, Ekaterini
    Lesiak, Maciej
    Lettino, Maddalena
    Mcguire, Darren K.
    Mullens, Wilfried
    Rocca, Bianca
    Sattar, Naveed
    [J]. EUROPEAN HEART JOURNAL, 2023, 44 (39) : 4043 - 4140
  • [22] The profiles of microRNAs from urinary extracellular vesicles (EVs) prepared by various isolation methods and their correlation with serum EV microRNAs
    Park, Sungjin
    Lee, Kiyoung
    Park, Ie Byung
    Kim, Nan Hee
    Cho, Seongcheol
    Rhee, Won Jong
    Oh, Yujin
    Choi, Jimin
    Nam, Seungyoon
    Lee, Dae Ho
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 160
  • [23] Extracellular vesicles as biomarkers and modulators of atherosclerosis pathogenesis
    Patel, Sarvatit
    Guo, Mandy Kunze
    Abdul Samad, Majed
    Howe, Kathryn L.
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [24] Atherosclerosis: cell biology and lipoproteins - focus on anti-inflammatory therapies
    Pfeiler, Susanne
    Gerdes, Norbert
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2018, 29 (01) : 53 - 55
  • [25] World Heart Federation Cholesterol Roadmap 2022
    Ray, Kausik K.
    Ference, Brian A.
    Severin, Tania
    Blom, Dirk
    Nicholls, Stephen J.
    Shiba, Mariko H.
    Almahmeed, Wael
    Alonso, Rodrigo
    Daccord, Magdalena
    Ezhov, Marat
    Olmo, Rosa Fernandez
    Jankowski, Piotr
    Lanas, Fernando
    Mehta, Roopa
    Puri, Raman
    Wong, Nathan D.
    Wood, David
    Zhao, Dong
    Gidding, Samuel S.
    Virani, Salim S.
    Lloyd-Jones, Donald
    Pinto, Fausto
    Perel, Pablo
    Santos, Raul D.
    [J]. GLOBAL HEART, 2022, 17 (01)
  • [26] Atherosclerosis is an inflammatory disease
    Ross, R
    [J]. AMERICAN HEART JOURNAL, 1999, 138 (05) : S419 - S420
  • [27] Lipoprotein Apheresis: Current Recommendations for Treating Familial Hypercholesterolemia and Elevated Lipoprotein(a)
    Safarova, Maya S.
    Moriarty, Patrick M.
    [J]. CURRENT ATHEROSCLEROSIS REPORTS, 2023, 25 (07) : 391 - 404
  • [28] Schatz U, 2023, DEUT MED WOCHENSCHR, V148, pE44, DOI 10.1055/a-1516-2761
  • [29] Effect of heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) apheresis on hepatitis C plasma virus load
    Schettler, V
    Monazahian, M
    Wieland, E
    Thomssen, R
    Müller, GA
    [J]. THERAPEUTIC APHERESIS, 2001, 5 (05): : 384 - 386
  • [30] The German Lipoprotein Apheresis Registry-Summary of the ninth annual report
    Schettler, Volker J. J.
    Peter, Christian
    Zimmermann, Thomas
    Julius, Ulrich
    Roeseler, Eberhard
    Schlieper, Georg
    Heigl, Franz
    Gruetzmacher, Peter
    Loehlein, Iris
    Klingel, Reinhard
    Hohenstein, Bernd
    Ramlow, Wolfgang
    Vogt, Anja
    [J]. THERAPEUTIC APHERESIS AND DIALYSIS, 2022, 26 : 81 - 88